FindTrial
Sign In

Study of soluble microneedles based on cystethione-ß-synthase inhibition in malignant melanoma

Study of soluble microneedles based on cystethione-ß-synthase inhibition in malignant melanoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096017
Enrollment
Unknown
Registered
2025-01-16
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant melanoma

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinically confirmed MM

Exclusion criteria

Exclusion criteria: 1.Other skin diseases and skin malignancies, severe systemic diseases, drug-induced dermatitis, etc. with similar manifestations of MM lesions.

Design outcomes

Primary

MeasureTime frame
Study the level of hydrogen sulfide (H2S) in MM;—

Countries

China

Contacts

Public ContactKeyu Zhao

The First Affiliated Hospital of Ningbo University

zky960114@163.com+86 13566017990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026